PELP1 and esophageal squamous cell carcinoma: Wang et al. showed that metformin, a widely used anti-diabetic drug, is able to activate the GSDMD-mediated pyroptosis of ESCC by targeting the miR-497/Proline-, glutamic acid- and leucine-rich protein-1 (PELP1) pathway to treat ESCC [80].